Welcome to our dedicated page for Birchtech SEC filings (Ticker: BCHT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Birchtech Corp. (BCHT) SEC filings, offering detailed insight into the company’s financial reporting, capital structure, and material events. Operating in the pollution and treatment controls industry, Birchtech focuses on specialty activated carbon technologies for air and water treatment, and its filings reflect revenue from product, license, equipment, and demonstrations/consulting categories.
Through Birchtech’s registration statements, such as its S‑1, investors can review information on business segments, revenue breakdowns, equity plans, and historical financial statements, including restatement adjustments to accumulated deficit and retained earnings. These documents outline how the company reports income from SEA ae sorbent licensing to coal-fired utilities, product and equipment activities, and consulting or demonstration services.
Current reports on Form 8‑K are particularly important for Birchtech. One 8‑K describes the final judgment entered in favor of the company by the U.S. District Court for the District of Delaware in a patent infringement action, including damages that incorporate pre‑judgment interest. Another 8‑K details the 1‑for‑5 reverse stock split of Birchtech’s common stock, explaining the certificate of amendment filed in Delaware, the effective date, and how outstanding shares and equity-linked securities are adjusted.
On this page, users can also follow quarterly and annual reports (Forms 10‑Q and 10‑K when filed), which typically contain management’s discussion and analysis, segment information, and disclosures relevant to Birchtech’s air and water businesses, intellectual property matters, and capital resources.
Stock Titan enhances these filings with AI-powered summaries that explain key sections, highlight changes from prior periods, and clarify technical language in documents such as 10‑K, 10‑Q, and 8‑K. Real-time updates from EDGAR mean that new filings, including any future registration statements, proxy materials, or Form 4 insider transaction reports, are added as they become available. This allows investors and researchers to quickly understand how legal judgments, reverse splits, equity awards, and revenue trends are reflected in Birchtech’s official SEC disclosures.
Birchtech Corp. is registering 4,819,278 shares of common stock in a primary offering at an assumed price of $4.15 per share, with a 30‑day option for underwriters to buy up to 722,892 additional shares. The company expects net proceeds of about $17.7 million, or $20.5 million if the option is fully exercised, to fund operating expenses, working capital and general corporate purposes.
Birchtech recently completed a 1‑for‑5 reverse stock split effective December 26, 2025 to help meet listing requirements and plans to move its shares from the OTCQB to the NYSE American under the symbol “BCHT,” which is a condition to closing this offering. Shares outstanding were 19,455,966 before the deal and would be 24,275,244 afterward, excluding the underwriters’ option.
The company provides specialty activated carbon technologies for mercury emissions control at coal‑fired power plants and is expanding into water treatment for PFAS and other contaminants. It discloses substantial doubt about its ability to continue as a going concern given a cash balance of approximately $2.3 million at December 31, 2025 and relies on expected litigation recoveries, new water‑business revenue, and this equity raise to improve liquidity.
Birchtech Corp. reports that on December 29, 2025, a U.S. District Court entered a final judgment in its favor in a previously disclosed patent infringement case against the remaining CERT defendants. The court awarded Birchtech $78,397,157.05 in damages, including pre-judgment interest.
The judgment follows a jury verdict returned on March 1, 2024 for Birchtech and subsequent post-trial proceedings. The court denied the CERT defendants’ motions on implied license and infringement liability, granted Birchtech’s request for pre- and post-judgment interest, and denied Birchtech’s request for enhanced damages.
Birchtech Corp. is implementing a 1-for-5 reverse stock split of its common stock. A certificate of amendment was filed in Delaware on December 23, 2025, making the split effective on December 26, 2025. Trading on a split-adjusted basis is expected to begin on December 31, 2025.
Every 5 issued and outstanding shares of common stock will be automatically converted into 1 share. Stockholders’ overall ownership percentage will stay the same, but any fractional share will be rounded up to the next whole share. The number of authorized shares and the $0.001 par value will not change, and outstanding equity awards, options and warrants will be adjusted proportionally.
The trading symbol BCHT will remain the same, though a temporary “D” will be added on the OTCQB for 20 business days. The company’s transfer agent, Transfer Online, Inc., will coordinate the exchange process, with book-entry and street-name holdings adjusted automatically.
Birchtech Corp. director David M. Kaye reported exercising stock options for 250,000 shares of common stock on 12/12/2025. The options had an exercise price of $0.58 per share. The transaction was structured as a cashless exercise, where 155,214 shares were withheld by the company at a VWAP of $0.9342 per share to pay the exercise cost, resulting in 94,786 net shares of common stock being issued to him.
After these transactions, Kaye directly beneficially owned 370,142 shares of Birchtech common stock, and the underlying stock option for 250,000 shares was fully exercised, leaving no derivative securities beneficially owned.
Birchtech Corp. insider Richard MacPherson, the company’s President, CEO, director and 10% owner, reported an option exercise and related share withholding. On 12/12/2025 he exercised a stock option for 500,000 shares of common stock at $0.58 per share using a cashless exercise.
To fund the exercise cost, 310,427 shares were withheld by Birchtech at a VWAP of $0.9342 per share, resulting in 189,573 net new shares of common stock being issued to him. After these transactions, he directly owns 13,212,954 shares of Birchtech common stock.
Birchtech Corp. reported an insider stock transaction by Senior VP and Chief Tech Officer John Pavlish. On 12/11/2025, he exercised a stock option to buy 300,000 shares of common stock at $0.58 per share through a cashless exercise.
To cover the cost, 190,560 shares were withheld by the company at a volume-weighted average price of $0.9131 per share, resulting in 109,440 shares of common stock being issued to him on a net basis. Following these transactions, he directly beneficially owned 2,198,528 shares of Birchtech common stock.
Birchtech Corp. (BCHT) filed its Q3 2025 report, showing a return to profitability for the quarter alongside a going concern warning. Revenue was $7.36M vs $5.24M a year ago, driven by $2.60M of license revenue and $4.72M of product sales. Gross profit reached $4.03M, and net income was $788,012, compared with a $458K loss last year.
For the nine months, revenue was $13.84M and the company posted a net loss of $2.43M. Cash was $1.77M at September 30, 2025, and management disclosed a working capital deficiency of about $5.0M, citing substantial doubt about continuing as a going concern. The balance sheet reflected a profit share liability of $7.62M measured on a Level 3 basis.
The company highlighted progress in patent enforcement and licensing, including a prior $57.1M jury verdict and multiple utility license agreements. Common shares outstanding were 96,866,109 as of November 13, 2025.